BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30541308)

  • 1. A Combined Bioinformatics and Literature Based Approach for Identification of Long Non-coding RNAs That Modulate Vitamin D Receptor Signaling in Breast Cancer.
    Kholghi Oskooei V; Ghafouri-Fard S; Omrani Mir D
    Klin Onkol; 2018; 31(4):264-269. PubMed ID: 30541308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D May Protect against Breast Cancer through the Regulation of Long Noncoding RNAs by VDR Signaling.
    Blasiak J; Chojnacki J; Pawlowska E; Jablkowska A; Chojnacki C
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D regulation of and by long non coding RNAs.
    Bikle DD
    Mol Cell Endocrinol; 2021 Jul; 532():111317. PubMed ID: 34015414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal pattern of vitamin D receptor-associated genes and lncRNAs in patients with bipolar disorder.
    Eghtedarian R; Ghafouri-Fard S; Bouraghi H; Hussen BM; Arsang-Jang S; Taheri M
    BMC Psychiatry; 2022 Mar; 22(1):178. PubMed ID: 35279108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between the vitamin D receptor (VDR) and miR-214 in regulating SuFu, a hedgehog pathway inhibitor in breast cancer cells.
    Alimirah F; Peng X; Gupta A; Yuan L; Welsh J; Cleary M; Mehta RG
    Exp Cell Res; 2016 Nov; 349(1):15-22. PubMed ID: 27693451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of vitamin D receptor in breast cancer: a systematic review and meta-analysis.
    Xu H; Liu Z; Shi H; Wang C
    BMC Cancer; 2020 Nov; 20(1):1051. PubMed ID: 33131491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNAs differential expression in breast cancer subtypes: What do we know?
    Mathias C; Zambalde EP; Rask P; Gradia DF; de Oliveira JC
    Clin Genet; 2019 May; 95(5):558-568. PubMed ID: 30614523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression analysis of vitamin D receptor-associated lncRNAs in epileptic patients.
    Mazdeh M; Zamani M; Eftekharian MM; Komaki A; Arsang-Jang S; Taheri M; Ghafouri-Fard S
    Metab Brain Dis; 2019 Oct; 34(5):1457-1465. PubMed ID: 31187385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay of long non-coding RNAs and TGF/SMAD signaling in different cancers.
    Farooqi AA; Attar R; Qureshi MZ; Fayyaz S; Sohail MI; Sabitaliyevich UY; Nurmurzayevich SB; Yelekenova A; Yaylim I; Alaaeddine N
    Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):1-6. PubMed ID: 30672446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the expression profile of vitamin D receptor and its related long non-coding RNAs in patients with acute lymphoblastic leukemia.
    Norouzi A; Motaghi M; Hassanshahi G; Nazari-Robati M
    Rev Assoc Med Bras (1992); 2021 Aug; 67(8):1113-1117. PubMed ID: 34669855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA profiling reveals new mechanism for VDR protection against skin cancer formation.
    Jiang YJ; Bikle DD
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():87-90. PubMed ID: 24342142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targets of vitamin D receptor signaling in the mammary gland.
    Welsh J
    J Bone Miner Res; 2007 Dec; 22 Suppl 2():V86-90. PubMed ID: 18290729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of long non-coding RNAs with a potential role in breast cancer.
    Heidari R; Akbariqomi M; Asgari Y; Ebrahimi D; Alinejad-Rokny H
    Mutat Res Rev Mutat Res; 2021; 787():108375. PubMed ID: 34083033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D receptor regulates autophagy in the normal mammary gland and in luminal breast cancer cells.
    Tavera-Mendoza LE; Westerling T; Libby E; Marusyk A; Cato L; Cassani R; Cameron LA; Ficarro SB; Marto JA; Klawitter J; Brown M
    Proc Natl Acad Sci U S A; 2017 Mar; 114(11):E2186-E2194. PubMed ID: 28242709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential modulation of hepatitis C virus replication and innate immune pathways by synthetic calcitriol-analogs.
    Saleh M; Welsch C; Cai C; Döring C; Gouttenoire J; Friedrich J; Haselow K; Sarrazin C; Badenhoop K; Moradpour D; Zeuzem S; Rueschenbaum S; Lange CM
    J Steroid Biochem Mol Biol; 2018 Oct; 183():142-151. PubMed ID: 29885880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA: a new player in 1α, 25(OH)(2) vitamin D(3) /VDR protection against skin cancer formation.
    Jiang YJ; Bikle DD
    Exp Dermatol; 2014 Mar; 23(3):147-50. PubMed ID: 24499465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel lncRNAs Co-Expression Networks Identifies LINC00504 with Oncogenic Role in Luminal A Breast Cancer Cells.
    Mathias C; Groeneveld CS; Trefflich S; Zambalde EP; Lima RS; Urban CA; Prado KB; Ribeiro EMSF; Castro MAA; Gradia DF; de Oliveira JC
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33670895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm.
    Trivedi T; Zheng Y; Fournier PGJ; Murthy S; John S; Schillo S; Dunstan CR; Mohammad KS; Zhou H; Seibel MJ; Guise TA
    Oncotarget; 2017 Apr; 8(16):26687-26701. PubMed ID: 28460457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatic approaches to interrogating vitamin D receptor signaling.
    Campbell MJ
    Mol Cell Endocrinol; 2017 Sep; 453():3-13. PubMed ID: 28288905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.